Overall, we provide evidence that a combined treatment approach consisting of suppressed p190RhoGAP expression into tumours and inactivation of p110δ PI3K in macrophages blocks melanoma and SCC progression by decreasing ATX expression levels. The gene discussed is ARHGAP35; the disease is neoplasm.